![](https://j9q7m2a3.rocketcdn.me/wp-content/uploads/2022/01/YOAST3.png)
MilliporeSigma Announces Closing of Mirus Bio Acquisition, Bolstering Viral Vector Bioproc
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced that the company’s Life Science business has closed the transaction to acquire Mirus Bio for approximately US$ 600 million (around € 550 million), …